Then in November 2010 she enrolled in a clinical
trial of a new class of drugs called PARP inhibitors.
Not exact matches
In particular, the complaint alleges that throughout the
Class Period, defendants made materially false and / or misleading statements and / or failed to disclose that (1) the
trials for GED - 0301 suffered from fatal design defects, such that GED - 0301 had failed to demonstrate meaningful clinical efficacy; (2) the growth
of Otezla sales had dramatically slowed during Celgene's third fiscal quarter
of 2017; and (3) the clinical and nonclinical pharmacology data in Celgene's
new drug application («NDA») for Ozanimod were insufficient to permit a complete review by the FDA, which resulted in the FDA issuing a refusal to file letter to Celgene regarding the NDA.
In a 564 - person
trial, patients whose ovarian cancer recurred (and who had already started treatment with chemotherapy) given Rubraca, part
of a
new class of cancer
drugs called «PARP» inhibitors, lived, on median, for double the amount
of time without their disease getting even worse compared with those given a placebo.
A wave
of encouraging clinical -
trial data is raising hopes for a
new class of drugs to treat rheumatoid arthritis.
Sangamo biochemist Philip Gregory notes that this Phase 1 clinical
trial is the first human test
of an entirely
new class of drug that could turn any gene on or off, depending on the disease.
Less than a decade after a powerful gene - silencing method — RNA interference, or just RNAi — was discovered, the field's pioneers have not only won the 2006 Nobel Prize in Physiology or Medicine but have also helped launch an entirely
new class of drugs into human clinical
trials.
18
Drugs Aim to Silence Bad Genes RNA interference helped launch an entirely new class of drugs into tria
Drugs Aim to Silence Bad Genes RNA interference helped launch an entirely
new class of drugs into tria
drugs into
trials...
Members
of this
new class of antiviral
drug are now in clinical
trials.
4/7/2008 From Bench to Bedside in One Year: Stem Cell Research Leads to Potential
New Therapy for Rare Blood Disorder A unique partnership between industry and academia has led to human clinical trials of a new drug for a rare class of blood diseases called myeloproliferative disorders (MPD), which are all driven by the same genetic mutation and can evolve into leuk... More
New Therapy for Rare Blood Disorder A unique partnership between industry and academia has led to human clinical
trials of a
new drug for a rare class of blood diseases called myeloproliferative disorders (MPD), which are all driven by the same genetic mutation and can evolve into leuk... More
new drug for a rare
class of blood diseases called myeloproliferative disorders (MPD), which are all driven by the same genetic mutation and can evolve into leuk... More...